富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/17 | 1,243 | 1,252 | 1,212 | 1,228 | -9 | -0.7% | 62,400 |
| 2024/09/13 | 1,246 | 1,253 | 1,232 | 1,237 | -15 | -1.2% | 53,600 |
| 2024/09/12 | 1,249 | 1,270 | 1,242 | 1,252 | +11 | +0.9% | 61,000 |
| 2024/09/11 | 1,265 | 1,269 | 1,234 | 1,241 | -29 | -2.3% | 54,900 |
| 2024/09/10 | 1,289 | 1,289 | 1,270 | 1,270 | -10 | -0.8% | 35,100 |
| 2024/09/09 | 1,239 | 1,284 | 1,238 | 1,280 | -10 | -0.8% | 85,700 |
| 2024/09/06 | 1,317 | 1,318 | 1,283 | 1,290 | -24 | -1.8% | 45,500 |
| 2024/09/05 | 1,287 | 1,326 | 1,284 | 1,314 | +13 | +1% | 58,200 |
| 2024/09/04 | 1,317 | 1,327 | 1,298 | 1,301 | -38 | -2.8% | 118,200 |
| 2024/09/03 | 1,336 | 1,343 | 1,330 | 1,339 | +2 | +0.1% | 88,000 |
| 2024/09/02 | 1,351 | 1,363 | 1,334 | 1,337 | -22 | -1.6% | 59,100 |
| 2024/08/30 | 1,343 | 1,359 | 1,335 | 1,359 | +29 | +2.2% | 77,900 |
| 2024/08/29 | 1,343 | 1,352 | 1,326 | 1,330 | -15 | -1.1% | 81,800 |
| 2024/08/28 | 1,358 | 1,358 | 1,336 | 1,345 | -28 | -2% | 61,300 |
| 2024/08/27 | 1,333 | 1,377 | 1,333 | 1,373 | +30 | +2.2% | 79,400 |
| 2024/08/26 | 1,354 | 1,359 | 1,333 | 1,343 | -12 | -0.9% | 82,100 |
| 2024/08/23 | 1,360 | 1,373 | 1,352 | 1,355 | +3 | +0.2% | 64,200 |
| 2024/08/22 | 1,352 | 1,369 | 1,346 | 1,352 | -3 | -0.2% | 77,000 |
| 2024/08/21 | 1,356 | 1,373 | 1,351 | 1,355 | -12 | -0.9% | 79,200 |
| 2024/08/20 | 1,382 | 1,391 | 1,350 | 1,367 | -2 | -0.1% | 181,600 |
| 2024/08/19 | 1,383 | 1,406 | 1,362 | 1,369 | +83 | +6.5% | 562,000 |
| 2024/08/16 | 1,280 | 1,287 | 1,264 | 1,286 | +34 | +2.7% | 81,800 |
| 2024/08/15 | 1,237 | 1,265 | 1,231 | 1,252 | +12 | +1% | 47,600 |
| 2024/08/14 | 1,223 | 1,243 | 1,210 | 1,240 | +18 | +1.5% | 82,900 |
| 2024/08/13 | 1,220 | 1,225 | 1,205 | 1,222 | +9 | +0.7% | 88,300 |
| 2024/08/09 | 1,279 | 1,279 | 1,183 | 1,213 | +23 | +1.9% | 172,000 |
| 2024/08/08 | 1,200 | 1,217 | 1,186 | 1,190 | -12 | -1% | 80,100 |
| 2024/08/07 | 1,161 | 1,237 | 1,161 | 1,202 | -13 | -1.1% | 127,100 |
| 2024/08/06 | 1,183 | 1,226 | 1,155 | 1,215 | +122 | +11.2% | 224,000 |
| 2024/08/05 | 1,178 | 1,214 | 1,089 | 1,093 | -175 | -13.8% | 252,100 |
| 2024/08/02 | 1,300 | 1,306 | 1,268 | 1,268 | -82 | -6.1% | 180,100 |
| 2024/08/01 | 1,402 | 1,402 | 1,349 | 1,350 | -55 | -3.9% | 98,600 |
| 2024/07/31 | 1,375 | 1,405 | 1,366 | 1,405 | +29 | +2.1% | 50,500 |
| 2024/07/30 | 1,392 | 1,392 | 1,369 | 1,376 | -15 | -1.1% | 82,100 |
| 2024/07/29 | 1,388 | 1,402 | 1,386 | 1,391 | +20 | +1.5% | 61,800 |
| 2024/07/26 | 1,383 | 1,395 | 1,371 | 1,371 | -11 | -0.8% | 82,700 |
| 2024/07/25 | 1,400 | 1,400 | 1,379 | 1,382 | -24 | -1.7% | 132,300 |
| 2024/07/24 | 1,427 | 1,433 | 1,406 | 1,406 | -28 | -2% | 84,400 |
| 2024/07/23 | 1,428 | 1,436 | 1,420 | 1,434 | +19 | +1.3% | 71,600 |
| 2024/07/22 | 1,458 | 1,460 | 1,414 | 1,415 | -51 | -3.5% | 221,800 |
| 2024/07/19 | 1,458 | 1,484 | 1,418 | 1,466 | -85 | -5.5% | 925,000 |
| 2024/07/18 | 1,555 | 1,570 | 1,551 | 1,551 | -13 | -0.8% | 56,200 |
| 2024/07/17 | 1,554 | 1,583 | 1,549 | 1,564 | +24 | +1.6% | 91,400 |
| 2024/07/16 | 1,550 | 1,565 | 1,540 | 1,540 | +8 | +0.5% | 78,600 |
| 2024/07/12 | 1,526 | 1,547 | 1,520 | 1,532 | -1 | -0.1% | 59,000 |
| 2024/07/11 | 1,523 | 1,537 | 1,511 | 1,533 | +35 | +2.3% | 69,300 |
| 2024/07/10 | 1,500 | 1,505 | 1,489 | 1,498 | -6 | -0.4% | 51,400 |
| 2024/07/09 | 1,480 | 1,521 | 1,478 | 1,504 | +14 | +0.9% | 103,900 |
| 2024/07/08 | 1,510 | 1,528 | 1,486 | 1,490 | -17 | -1.1% | 66,500 |
| 2024/07/05 | 1,475 | 1,510 | 1,475 | 1,507 | +32 | +2.2% | 104,000 |
151～
200
件表示中 / 6944件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 135,700円 | +15.7% | +5.3% | 3.35% | 9.81倍 | 0.73倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| タウンズ | 50,500円 | +4.6% | +6.1% | 5.54% | 8.59倍 | 3.18倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| 生化学 | 70,400円 | +9.2% | +39.0% | 4.26% | 23.29倍 | 0.51倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,000円 | +150.0% | - | 0.00% | - | 15.74倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 208,000円 | +4.5% | -33.7% | 3.37% | 20.95倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
市場注目の銘柄
チャート関連のコラム
